Lens subluxation is more efficiently managed by phacoemulsification

Article

Lens subluxation and lens coloboma are better managed by phacoemulsification rather than manual small incision cataract surgery (MSICS).

Lens subluxation and lens coloboma are better managed by phacoemulsification rather than manual small incision cataract surgery (MSICS), reveals a study in The Journal of the British Contact Lens Association.

The investigation, led by Dr Saurabh Kamal, Guru Nanak Eye Centre, New Delhi, India, included a patient with bilateral isolated lens coloboma. In the left eye MSICS was performed and in the right eye phacoemulsification was conducted.

Lens extraction was indicated for cataract or subluxation by determining if visual function was adequately compromised.

The results revealed that nuclear rotation was disturbed due to a lack of zonules and lens coloboma presence. In the right eye the nucleus was broken during phacoemulsification. This allowed the successful implantation of a modified capsule tension ring.

In conclusion, eyes with lens coloboma are more at risk of complications during cataract surgery, so phacoemulsification is the safest and most successful treatment option.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.